Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.3 USD | -0.67% | +0.43% | +509.29% |
05-09 | Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | North American Morning Briefing : Stocks Seen -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+509.29% | 69.71M | |
+31.16% | 49.46B | |
+1.13% | 42.58B | |
+49.05% | 42.49B | |
-5.26% | 29.09B | |
+12.66% | 26.61B | |
-23.80% | 18.64B | |
+7.25% | 13.16B | |
+31.42% | 12.55B | |
+23.06% | 12.1B |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- Raymond James Downgrades Landos Biopharma to Market Perform From Outperform